|
About the Networking and learning resources category
|
|
0
|
50
|
August 22, 2024
|
|
Where to buy affordable peg interferon 2a
|
|
1
|
100
|
September 29, 2026
|
|
Brelovitug Meets Primary Endpoint in Phase 3 AZURE-1 Hepatitis Delta Trial
|
|
1
|
135
|
September 29, 2026
|
|
Vemlidy (TAF) Now Covered by CNAS in Romania: Good News for Hepatitis B Patients
|
|
2
|
158
|
September 15, 2026
|
|
For both affected community and researchers: videos available from World Hepatitis Summit 2026
|
|
8
|
280
|
August 26, 2026
|
|
Ausper Bio AHB-171
|
|
12
|
739
|
August 20, 2026
|
|
Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China
|
|
0
|
111
|
August 15, 2026
|
|
Hepatitis B in Nigeria: discussion thread
|
|
66
|
2261
|
August 11, 2026
|
|
New Drugs to cure Hep B?
|
|
237
|
22494
|
August 2, 2026
|
|
New strategy could prevent T cell exhaustion and boost immunotherapy
|
|
1
|
163
|
August 2, 2026
|
|
Dr. Su Wang Event: "What's New in Hep B Care & What to Ask Your Doctor" (7/15 at 7 PM EST)
|
|
5
|
269
|
August 2, 2026
|
|
New HBV Treatment Guidelines from APASL (Asia Pacific Liver Society)
|
|
1
|
297
|
July 9, 2026
|
|
Brii Bio’s ENRICH Study Shows 42.9% HBsAg Loss in Hepatitis B
|
|
3
|
291
|
July 4, 2026
|
|
Aligos Therapeutics Enters into Exclusive License Deal with Xiamen Amoytop Biotech Co., Ltd. to Develop and Commercialize Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection
|
|
10
|
658
|
June 30, 2026
|
|
Phase 3 results of Bepirovirsen treatment reveals 20-percent functional cure rate
|
|
35
|
1955
|
June 9, 2026
|
|
FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection
|
|
5
|
316
|
May 24, 2026
|
|
Webinar Today (4/15) Nutrition for Hep B with Dr. Jennifer C. Lai
|
|
6
|
224
|
May 22, 2026
|
|
Watch Tonight at 6pm ET - "A Liver Healthy Diet - What Hep B Patients Need to Know"
|
|
0
|
109
|
May 20, 2026
|
|
Hap b functional approvals and phases
|
|
3
|
493
|
May 15, 2026
|
|
The recent passing of Kinoti
|
|
10
|
1335
|
May 12, 2026
|
|
GSK enters exclusive collaboration with SBP Group, a market leader in hepatology in China, to accelerate bepirovirsen at launch
|
|
0
|
198
|
May 11, 2026
|
|
New AI Blood Test Detects Silent Liver Disease Before Symptoms Appear
|
|
0
|
155
|
May 10, 2026
|
|
Chronic Hepatitis B Infection: Patient Guidance (Chinese & English)
|
|
2
|
223
|
May 8, 2026
|
|
New hep B campaign in Australia!
|
|
0
|
100
|
May 4, 2026
|
|
Bepirovirsen accepted for priority review by the US FDA
|
|
4
|
352
|
May 1, 2026
|
|
Clinical cure of chronic hepatitis B is associated with priming and perpetuation of hepatic CD4+ T cell responses
|
|
0
|
158
|
May 1, 2026
|
|
Scientists Find Way to Reverse Fatty Liver Disease Without Changing Diet
|
|
3
|
248
|
April 28, 2026
|
|
Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026
|
|
0
|
126
|
April 27, 2026
|
|
A New Path Toward a Functional Cure for Chronic Hepatitis B
|
|
0
|
255
|
April 23, 2026
|
|
Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B
|
|
0
|
140
|
April 15, 2026
|